Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines

Cancer Research

Volumn 60, Issue 3, 2000, Pages 760-765

  Nakamura, Keiichiro ^a   Hongo, Atsushi ^a   Kodama, Junichi ^a   Miyagi, Yasunari ^a   Yoshinouchi, Mitsuo ^a   Kudo, Takafumi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; MESSENGER RNA; SOMATOMEDIN C RECEPTOR;

ARTICLE; CELL TRANSFORMATION; COLONY FORMATION; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; UTERINE CERVIX CANCER; WART VIRUS;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PHENOTYPE; RECEPTOR, IGF TYPE 1; RNA, ANTISENSE; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0033952237     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Baserga, R., Hongo, A., Rubini, M., Prisco, M., and Valentinis, B. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim. Biophys. Acta, 1332: 105-126, 1997.
2. Leof, E. B., Wharton, W., Van Wyk, J. J., and Pledgar, W. J. Epidermal growth factor (EGF) and somatomedin C-regulated G1 progression in competent BALB/c3T3 cells. Exp. Cell Res., 141: 107-115, 1982.
3. Stiles, C. D., Capone, G. T., Scher, C. D., Antodiades, H. N., Van Wyk, J. J., and Pledger, W. J. Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc. Natl. Acad. Sci. USA, 76: 1279-1283, 1979.
4. Baserga, R., Sell, C., Porcu, P., and Rubini, M. The role of the IGF-I receptor in the growth and transformation of mammalian cells. Cell Prolif., 27: 63-71, 1994.
5. Baserga, R. The insulin-like growth factor 1 receptor: a key to tumor growth? Cancer Res., 55: 249-252, 1995.
6. Kaleko, M., Rutter, W. G., and Mille, A. D. Overexpression of the human insulin-like growth factor I receptor promotes ligand-independent neoplastic transformation. Mol. Cell. Biol., 10: 454-473, 1990.
7. Harrington, E. A., Bennett, M. R., Fanidi, A., and Evan, G. I. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J., 13: 3286-3295, 1994.
8. Sell, C., Baserga, R., and Rubin, R. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res., 55: 303-306, 1995.
9. Prisco, M., Hongo, A., Rizzo, M. G., Sacchi, A., and Baserga R. The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal. Mol. Cell. Biol., 17: 1084-1092, 1997.
10. Nakamura, S., Watanabe, H., Miura, M., and Sasaki, T. Effect of the insulin-like growth factor I receptor on ionizing radiation-induced cell death in mouse embryo fibroblasts. Exp. Cell. Res., 235: 287-294, 1997.
11. Resnicoff, M., Abraham, D., Yutanawiboonchai, W., Rotman, H., Kajstura, J., Rubin, R., Zoltick, P., and Baserga, R. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res., 55: 2463-2469, 1995.
12. Trojan, J., Johnson, T. R., Rudin, S. D., Ilan, M., Tykocinski, M., and Ilan, J. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science (Washington DC), 259: 94-97, 1993.
13. Resnicoff, M., Sell, C., Rubini, M., Coppola, D., Ambrose, D., Baserga, R., and Rubin, R. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-I (IGF-I) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res., 54: 2218-2222, 1994.
14. Resnicoff, M., Coppola, D., Sell, C., Rubin, R., Ferrone, S., and Baserga, R. Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res., 54: 4848-4850, 1994.
15. Shapiro, D. N., Jones, B. G., Shapiro, L. H., Dias, P., and Houghton, P. J. Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma. J. Clin. Investig., 94: 1235-1242, 1994.
16. Neuenschwander, S., Roberts, C. T., Jr., and LeRoith, D. Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor I receptor antisense ribonucleic acid. Endocrinology, 136: 4298-4303, 1995.
17. Burfeind, P., Chernicky, C. L., Rininsland, F., Ilan, J., and Ilan, J. Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo. Proc. Natl. Acad. Sci. USA, 93: 7263-7268, 1996.
18. Prager, D., Li, H. L., Asa, S., and Melmed, S. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc. Natl. Acad. Sci. USA, 91: 2181-2185, 1994.
19. Burgaud, J. L., Resnicoff, M., and Baserga, R. Mutant IGF-I receptors as dominant negatives for growth and transformation. Biochem. Biophys. Res. Commun., 214: 475-481, 1995.
20. D'Ambrosio, C., Ferber, A., Resnicoff, M., and Baserga, R. A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. Cancer Res., 56: 4013-4020, 1996.
21. Reiss, K., D'Ambrosio, C., Tu, X., Tu, C., and Baserga, R. Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect. Clin. Cancer Res., 4: 2647-2655, 1998.
22. Rininsland, F., Johnson, T. R., Chernicky, C. L., Schulze, E., Burfeind, B., and Ilan, J. Suppression of insulin-like growth factor type I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells. Proc. Natl. Acad. Sci. USA, 94: 5854-5859, 1997.
23. Hongo, A., Yumet, G., Resnicoff, M., Romano, G., O'Connor, R., and Baserga, R. Inhibition of tumorigenesis and induction of apoptosis in human tumor cells by the stable expression of a myristylated COOH terminus of the insulin-like growth factor I receptor. Cancer Res., 58: 2477-2484, 1998.
24. Liu, J. P., Baker, J., Perkins A. S., Robertson, E. J., and Efstratiadis, A. Mice carrying null mutation of the gene encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (IgfIr). Cell, 75: 59-72, 1993.
25. Baker, J., Liu, J. P., Robertson, E. J., and Efstratiadis, A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell, 75: 73-82, 1993.
26. Sell, C., Rubini, M., Liu, J. P., Efstratiadis, A., and Baserga, R. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc. Natl. Acad. Sci. USA, 90: 11217-11221, 1993.
27. Sell, C., Dumenil, G., Deveaud, C. Miura, M., Coppola, D., DeAngelis, T., Rubin, R., Efstratiadis, A., and Baserga, R. Effect of a null mutation of the type 1 IGF receptor gene on growth and transformation of mouse embryo fibroblasts. Mol. Cell. Biol., 14: 3604-3612, 1994.
28. Morrione, A., DeAngelis, T., and Baserga, R. Failure of the bovine papillomavirus to transform mouse embryo fibroblasts with a targeted disruption of the insulin-like growth factor I receptor genes. J. Virol., 69: 5300-5303, 1995.
29. Valentinis, B., Morrione, A., Taylor, S. J., and Baserga, R. Insulin-like growth factor I receptor signaling in transformation by src oncogene. Mol. Cell Biol., 17: 3744-3754, 1997.
30. Coppola, D., Ferber, A., Miura, M., Sell, C., D'Ambrosio, C., Rubin, R., and Baserga, R. A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol. Cell. Biol., 14: 4588-4595, 1994.
31. DeAngelis, T., Ferber, A., and Baserga, R. Insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the platelet-derived growth factor receptor. J. Cell. Physiol., 164: 214-221, 1995.
32. Steler, M. A., Zou, Z., Schiller, J. T., and Baserga, R. Transformation by human papillomavirus 16 E6 and E7: role of the insulin-like growth factor I receptor. Cancer Res., 56: 5087-5091, 1996.
33. zur Hausen, H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology, 184: 9-13, 1991.
34. Riou, G., Favre, M., Jeannel, D., Bourhis, J., LeDoussal, V., and Orth, G. Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet, 335: 1171-1174, 1990.
35. Schwarz, E., Freese, U. K., Gissmann, L., Mayer, W., Roggenhuck, B., Stremlau, A., and zur Hausen, H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature (Lond.), 314: 111-114, 1985.
36. Yee, C. L., Krishnan-Hewlett, I., Baker, C. C., Schlegel, R., and Howley, P. M. Presence and expression of human papillomavirus sequence in human cervical carcinoma cell lines. Am. J. Pathol., 119: 3261-3266, 1985.
37. Scheffner, M., Münger, K., Byrne, J. C., and Howley, P. M. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA, 88: 5523-5527, 1991.
38. Rubini, M., Hongo, A., D'Ambrosio, C., and Baserga, R. The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number. Exp. Cell Res., 230: 284-292, 1997.
39. Ambrose, D., Resnicoff, M., Coppola, D., Sell, C., Miura, M., Jameson, S., Baserga, R., and Rubin, R. Growth regulation of human glioblastoma T98G cells by insulin-like growth factor-I and its receptor. J. Cell. Physiol., 159: 92-100, 1994.
40. Craig, E., McCathy, B. J., and Wadsworth, S. C. Sequence organization of two recombinant plasmids containing genes for the major heat shock-induced protein of D. melanogaster. Cell, 16: 575-588, 1979.
41. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., and Howley, P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63: 1129-1136, 1990.
42. Dyson, M., Howley, P. M., Münger, K., and Harlow, E. The human papillomavirus 16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (Washington DC), 243: 934-937, 1989.
43. Münger, K., Phelps, W. C., Bubb, V., Howley, P. M., and Schelegel, R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol., 63: 4417-4421, 1989.
44. Larson, A. A., Liao, S. Y., Stanbridge, E. J., Cavenee, W. K., and Hampton, G. M. Genetic alterations accumulate during cervical tumorigenesis and indicate a common origin for multifocal lesions. Cancer Res., 57: 4171-4176, 1997.
45. Drummond-Barbosa, D., and DiMaio, D. Virocrine transformation. Biochim. Biophys. Acta, 1332: M1-M17, 1997.
46. Porcu, P., Ferber, A., Pietrzkowski, Z., Roberts, C. T., Adamo, M., LeRoith, D., and Baserga, R. The growth-stimulatory effect of simian virus 40 T antigen requires the interaction of insulin-like growth factor I with its receptor. Mol. Cell. Biol., 12: 5069-5077, 1992.
47. Zhou-li, F., D'Ambrosio, C., Li, S., Surmacz, E., and Baserga, R. Association of insulin receptor substrate I with simian virus 40 large T antigen. Mol. Cell. Biol. 15: 4232-4239, 1995.
48. Kozma, L. M., and Weber, M. J. Constitutive phosphorylation of the receptor for insulin-like growth factor I in cells transformed by the src oncogene. Mol. Cell. Biol., 10: 3626-3634, 1990.
49. Petti L., and DiMaio, D. Stable association between the bovine papillomavirus E5 transforming protein and activated platelet-derived growth factor receptor in transformed mouse cells. Proc. Natl. Acad. Sci. USA, 89: 6736-6740, 1992.
50. Tan, T. M., Ting, R. C. In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes. Cancer Res., 75: 4599-4605, 1995.
51. Hamada, K., Sakaue, M., Alemany, R., Zhang, W. W., Horio, Y., Roth, J. A., and Mitchell, M. F. Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells. Gynecol. Oncol., 63: 219-227, 1996.
52. Wang-Johanning, F., Gillespie, G. Y., Grim, J., Rancourt, C., Alvarez, R. D., Siegal, G. P., and Curiel, D. T. Intracellular expression of a single-chain antibody directed against human papillomavirus type 16 E7 oncoprotein achieves targeted antineoplastic effects. Cancer Res., 58: 1893-1900, 1998.